Работы, цитирующие эту работу

Работ: 2

Работа: Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer’s disease neuropathological deficits

1. Insights Into the Therapeutic Potential of SIRT1-modifying Compounds for Alzheimer’s Disease: A Focus on Molecular Mechanisms

   Dhyauldeen Aftan Al-Hayani, Aziz Kubaev, Subasini Uthirapathy +7

   Обзорная статьяSirtuins and Resveratrol in MedicineJournal of Molecular Neuroscience2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000029

2. Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease

   Mohamed J. Saadh, Faris Anad Muhammad, Tuqa S. Alazzawi +5

   Обзорная статьяMicroRNA in disease regulationMolecular Neurobiology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000090